Teriparatide subcutaneous injection 56.5μg “Sawai”, by Sawai Pharmaceutical, contains teriparatide acetate. It is indicated for the treatment of osteoporosis, promoting bone formation to reduce fracture risk. This formulation comes as 56.5μg 1 bottle (with dissolving solution) (YJ code: 2439401D2032).
Teriparatide subcutaneous injection 56.5μg “Sawai”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →